|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2005;80:2000-2001
© 2005 The Society of Thoracic Surgeons
Department of Oncological and Regenerative Surgery, University of Tokushima Graduate School, Kuramoto-cho, Tokushima, 770-8503 Japan
(Email: kondo@clin.med.tokushima-u.ac.jp).
| The first 20% of the full text of this article appears below. |
The idea of clinical staging of thymoma was introduced by Bergh and colleagues [1], which was later modified by Wilkins and Castleman [2], and was advanced by Masaoka and associates [3] in 1981. Masaoka's system has been widely adopted and is an excellent system for predicting prognosis for thymomas. Several articles including the article by Bedini and associates [4] have pointed out problems and have suggested that an update of the system is desirable.
The authors identified seven major
This article has been cited by other articles:
![]() |
T. Utsumi and M. Okumura A Staging System for Thymic Epithelial Tumors: More Discussion is Required. Ann. Thorac. Surg., September 1, 2006; 82(3): 1170 - 1170. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |